PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CHRONIC HEART FAILURE COMPRISING PYRAZOLOPYRIMIDINONE DERIVATIVE COMPOUND

摘要

Disclosed is the use of a pyrazoloprimidinone derivative represented by Formula 1 for the treatment of chronic heart failure. The derivative can inhibit cardiac morphological changes, ventricular cavity enlargement and changes in ventricular wall thickness.